Doximity, Inc.

NYSE:DOCS Lagerbericht

Marktkapitalisierung: US$5.3b

Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Doximity Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Doximity wird ein jährliches Gewinn- und Umsatzwachstum von 9.6% bzw. 9.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 11.6% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 19.1% betragen.

Wichtige Informationen

9.6%

Wachstumsrate der Gewinne

11.6%

EPS-Wachstumsrate

Healthcare Services Gewinnwachstum27.9%
Wachstumsrate der Einnahmen9.6%
Zukünftige Eigenkapitalrendite19.1%
Analystenabdeckung

Good

Zuletzt aktualisiert22 May 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Doximity Earnings: Better Than Expected, But Still Mixed Outlook (Rating Upgrade)

May 17

Capital Allocation Trends At Doximity (NYSE:DOCS) Aren't Ideal

May 04
Capital Allocation Trends At Doximity (NYSE:DOCS) Aren't Ideal

Doximity: Significant Upside Remains, But Not Until The Growth Story Returns

Apr 29

With Doximity, Inc. (NYSE:DOCS) It Looks Like You'll Get What You Pay For

Apr 16
With Doximity, Inc. (NYSE:DOCS) It Looks Like You'll Get What You Pay For

Estimating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Mar 26
Estimating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Doximity: Rating Upgrade To Buy As Outlook Turns Positive

Feb 21

We Like Doximity's (NYSE:DOCS) Earnings For More Than Just Statutory Profit

Feb 15
We Like Doximity's (NYSE:DOCS) Earnings For More Than Just Statutory Profit

What Is Doximity, Inc.'s (NYSE:DOCS) Share Price Doing?

Feb 13
What Is Doximity, Inc.'s (NYSE:DOCS) Share Price Doing?

Doximity: Downside Is Contained, While Upside Depends On Management's Game Plan

Jan 16

Doximity (NYSE:DOCS) May Have Issues Allocating Its Capital

Jan 04
Doximity (NYSE:DOCS) May Have Issues Allocating Its Capital

Doximity, Inc.'s (NYSE:DOCS) Intrinsic Value Is Potentially 29% Above Its Share Price

Dec 14
Doximity, Inc.'s (NYSE:DOCS) Intrinsic Value Is Potentially 29% Above Its Share Price

Doximity Earnings: Steer Clear Of This Rollercoaster War Of Optimism Vs. Skepticism

Nov 10

Doximity: Adding Value Using AI But Faces Near-Term Risks

Nov 01

Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?

Oct 30
Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?

Doximity (NYSE:DOCS) Might Be Having Difficulty Using Its Capital Effectively

Sep 25
Doximity (NYSE:DOCS) Might Be Having Difficulty Using Its Capital Effectively

Doximity: Rating Downgrade As Investors Shift Focus To The Near-Term Outlook

Aug 24

Doximity Earnings: Too Many Problems, Sell

Aug 09

A Look At The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)

Jul 29
A Look At The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)

Why Doximity, Inc. (NYSE:DOCS) Could Be Worth Watching

Jul 09
Why Doximity, Inc. (NYSE:DOCS) Could Be Worth Watching

Doximity: Continue To See Positive Upside From Current Stock Level

Jul 05

The Returns At Doximity (NYSE:DOCS) Aren't Growing

Jun 21
The Returns At Doximity (NYSE:DOCS) Aren't Growing

Doximity: Digital Health Play With Strong Fundamentals

Jun 21

A Look At The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Apr 07
A Look At The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Doximity (NYSE:DOCS) Is Reinvesting At Lower Rates Of Return

Mar 20
Doximity (NYSE:DOCS) Is Reinvesting At Lower Rates Of Return

Doximity: Good Business But Extremely Overvalued

Feb 18

Doximity Q3 Earnings: Disappointing Results

Feb 10

Calculating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Dec 25
Calculating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Doximity: On The Right Path To Further Consolidate Market Share

Dec 22

Here's What's Concerning About Doximity's (NYSE:DOCS) Returns On Capital

Dec 04
Here's What's Concerning About Doximity's (NYSE:DOCS) Returns On Capital

Doximity up 16% after fiscal 2023 Q2 beats, FY revenue range includes consensus

Nov 10

Doximity, down 9%, falls below IPO price

Oct 12

Doximity Appears Well-Positioned But Shares May Be Fully Valued Here

Aug 11

Doximity Non-GAAP EPS of $0.14 beats by $0.03, revenue of $90.6M beats by $0.95M

Aug 04

Unpleasant Surprises Could Be In Store For Doximity, Inc.'s (NYSE:DOCS) Shares

Jul 09
Unpleasant Surprises Could Be In Store For Doximity, Inc.'s (NYSE:DOCS) Shares

Pair Trade: Going Long Doximity And Short Teladoc

Jul 05

Doximity: Slowing Guidance, Stock Drops, But It Oozes Cash Flows

May 18

Gewinn- und Umsatzwachstumsprognosen

NYSE:DOCS - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
3/31/20276212002332427
3/31/202656115622022914
3/31/202551314320620917
3/31/2024475148178184N/A
12/31/2023468138162167N/A
9/30/2023448123160165N/A
6/30/2023437119186192N/A
3/31/2023419113173180N/A
12/31/2022402119173180N/A
9/30/2022384141151159N/A
6/30/2022362148131138N/A
3/31/2022344133121127N/A
12/31/2021317107113117N/A
9/30/202127757110114N/A
6/30/202124330103107N/A
3/31/2021207227883N/A
12/31/2020177144853N/A
3/31/2020116112226N/A
3/31/20198611415N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: DOCSDas prognostizierte Gewinnwachstum (9.6% pro Jahr) liegt über der Sparquote (2.4%).

Ertrag vs. Markt: DOCSDie Erträge des Unternehmens (9.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (14.7% pro Jahr).

Hohe Wachstumserträge: DOCSDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: DOCSDie Einnahmen des Unternehmens (9.6% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (8.4% pro Jahr).

Hohe Wachstumseinnahmen: DOCSDie Einnahmen des Unternehmens (9.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: DOCSDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (19.1 %).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y